Photo taken from Michail Ignatiadis/Twitter
Sep 15, 2023, 18:51
Michail Ignatiadis: Join us tomorrow with Peter Fasching, Sara Tolaney and Stephen Johnston to discuss QoL in the phase 3 NATALEE trial of adjuvant ribociclib
Quoting Michail Ignatiadis, Jules Bordet Institute, on Twitter:
“Join us tomorrow with Peter Fasching, Sara Tolaney and Stephen Johnston to discuss QoL in the phase 3 NATALEE trial of adjuvant ribociclib, ESMO Virtual Plenary with AACR Expert Commentary: September 2023″
For details click here.
Source: Michail Ignatiadis/Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 19:25
Nov 13, 2024, 16:51
Nov 13, 2024, 16:49
Nov 13, 2024, 16:45
Nov 13, 2024, 16:25
Nov 13, 2024, 16:23
Nov 13, 2024, 16:08